---identifier: "/us/cfr/t10/s35.69"source: "ecfr"legal_status: "authoritative_unofficial"title: "10 CFR § 35.69 - Labeling of vials and syringes."title_number: 10title_name: "Energy"section_number: "35.69"section_name: "Labeling of vials and syringes."chapter_name: "NUCLEAR REGULATORY COMMISSION"part_number: "35"part_name: "MEDICAL USE OF BYPRODUCT MATERIAL"positive_law: falsecurrency: "2026-03-24"last_updated: "2026-03-24"format_version: "1.1.0"generator: "[email protected]"authority: "Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (42 U.S.C. 2111, 2201, 2231, 2232, 2233, 2273, 2282, 2021); Energy Reorganization Act of 1974, secs. 201, 206 (42 U.S.C. 5841, 5846); 44 U.S.C. 3504 note."regulatory_source: "67 FR 20370, Apr. 24, 2002, unless otherwise noted."cfr_part: "35"---
Identifier
/us/cfr/t10/s35.69
Currency
2026-03-24
Positive Law
No
Updated
2026-03-24
Chapter
Nuclear Regulatory Commission
Authority
Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (42 U.S.C. 2111, 2201, 2231, 2232, 2233, 2273, 2282, 2021); Energy Reorganization Act of 1974, secs. 201, 206 (42 U.S.C. 5841, 58... Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (42 U.S.C. 2111, 2201, 2231, 2232, 2233, 2273, 2282, 2021); Energy Reorganization Act of 1974, secs. 201, 206 (42 U.S.C. 5841, 5846); 44 U.S.C. 3504 note.
# 35.69 Labeling of vials and syringes.Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radioactive drug. Each syringe shield and vial shield must also be labeled unless the label on the syringe or vial is visible when shielded.